Please Wait.....
Report
Europe Influenza Vaccines Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Vaccine Type (Quadrivalent Vaccines and Trivalent Vaccines), Virus Type (Influenza Virus Type A and Influenza Virus Type B), Technology (Egg-based and Cell-based), Route of Administration (Injection and Nasal Spray), and Target Group (Infants, Children, Adults, and Elderly People)
Market Report I 2023-01-11 I 156 Pages I The Insight Partners
The influenza vaccines market in Europe is expected to grow from US$ 2,261.85 million in 2022 to US$ 3,424.02 million by 2028; it is estimated to grow at a CAGR of 7.2% from 2022 to 2028.
Increasing Investment by Top Market Players and Governments Boosts Europe Influenza Vaccines Market
Market players and governments worldwide are increasing their investments in vaccine development and immunization. For instance, in March 2021, Sanofi (Paris, France) announced an approximately US$ 925 million investment in a new vaccine manufacturing plant at its pre-existing site in Toronto, Canada. Investments in the new facility will provide additional antigen and filling capacity for Sanofi's FLUZONE high-dose quadrivalent influenza vaccines, increasing availability in Canada, the US, and Europe in the coming years. In April 2021, 3 levels of government-federal, provincial, and municipal-supported Sanofi Pasteur in building an "end-to-end" influenza vaccines factory in Toronto. The partners will invest ~US$ 1 billion to get the site up and running by 2027. Sanofi, for its part, will invest more than US$ 55 million, create 165 new eligible jobs, and maintain another 1,100. In addition, Sanofi will also invest ~US$ 79 million annually for 8 years to fund research and development in Canada.
In June 2021, The European Investment Bank signed a US$ 30.55 million global vaccine distribution agreement with biotech company Univercells to mass produce the COVID-19 vaccine at a new Belgian site. It helped build other vaccine factories across the world. In April 2022, the bank provided a US$ 15.27 million loan to IRBM, an Italian biomedical research company, to expand its vaccine production capacity and strengthen research on COVID-19 and other diseases. Thus, the increase in investment by top market players and governments across the region is bolstering the Europe influenza vaccines market.
Market Overview
Europe accounted for the second largest market owing to factors such as the rising geriatric population, increasing prevalence of flu and related illness, and growing demand for the development of new vaccines in the region. In addition, growing funding for research & development activities is likely to provide more opportunities in the coming years across the region.
Europe Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Million)
Europe Influenza Vaccines Market Segmentation
The Europe influenza vaccines market is segmented on the basis of vaccine type, virus type, technology, route of administration, target group, and country.
Based on vaccine type, the Europe influenza vaccines market is bifurcated into quadrivalent vaccines and trivalent vaccines. The quadrivalent vaccines segment registered a larger share of the market in 2022.
Based on virus type, the Europe influenza vaccines market is bifurcated into influenza virus type A and influenza virus type B. The influenza virus type A segment held a larger share of the market in 2022.
Based on technology, the Europe influenza vaccines market is divided into egg-based and cell-based. The egg-based segment held a larger share of the market in 2022.
Based on route of administration, the Europe influenza vaccines market is divided into injection and nasal spray. The injection segment held a larger share of the market in 2022.
Based on target group, the Europe influenza vaccines market is segmented into infants, children, adults, and elderly people. The infants segment held the largest share of the market in 2022.
Based on country, the Europe influenza vaccines market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. The UK dominated the market in 2022.
AstraZeneca; Emergent BioSolutions Inc.; GlaxoSmithKline plc.; Mitsubishi Chemical Group Corporation; Moderna, Inc.; MYLAN N.V.; Sanofi; SEQIRUS; and Serum Institute of India Pvt. Ltd are the leading companies operating in the influenza vaccines market in Europe.
TABLE OF CONTENTS
1. Introduction
1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Influenza Vaccines Market - By Vaccine Type
1.3.2 Europe Influenza Vaccines Market - By Virus Type
1.3.3 Europe Influenza Vaccines Market - By Technology
1.3.4 Europe Influenza Vaccines Market - By Route of Administration
1.3.5 Europe Influenza Vaccines Market - By Target Group
1.3.6 Europe Influenza Vaccines Market - By Country
2. Europe Influenza Vaccines Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Influenza Vaccines Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Europe PEST Analysis
4.3 Experts Opinion
5. Europe Influenza Vaccines Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increase in Government Support to Promote Influenza Vaccination
5.1.2 Increasing Investment by Top Market Players and Governments
5.2 Market Restraints
5.2.1 High Cost of Vaccine Development
5.3 Market Opportunities
5.3.1 Emerging Economies
5.4 Future Trends
5.4.1 Strong Pipeline Candidates for Influenza Vaccines
5.5 Impact Analysis
6. Influenza Vaccine Market -Europe Analysis
6.1 Europe Influenza Vaccines Market, By Country - Forecasts And Analysis
6.2 Europe Influenza Vaccines Market Revenue Forecasts And Analysis
6.2.1 Europe: Influenza Vaccines Market, 2019-2028 (US$ Million)
7. Europe Influenza Vaccines Market Analysis and Forecasts To 2028 - By Vaccine Type
7.1 Overview
7.2 Europe Influenza Vaccines Market, By Vaccine Type 2022 & 2028 (%)
7.2.1 Europe: Influenza Vaccines Market, by Vaccine Type, 2019-2028 (US$ Million)
7.3 Quadrivalent Vaccines
7.3.1 Overview
7.3.2 Quadrivalent Vaccines : Europe Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
7.4 Trivalent Vaccines
7.4.1 Overview
7.4.2 Trivalent Vaccines : Europe Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
8. Europe Influenza Vaccines Market Analysis and Forecasts To 2028 - By Virus Type
8.1 Overview
8.2 Europe Influenza Vaccines Market, By Virus Type 2022 & 2028 (%)
8.2.1 Europe: Influenza Vaccines Market, by Virus Type, 2019-2028 (US$ Million)
8.3 Influenza Virus Type A
8.3.1 Overview
8.3.2 Influenza Virus Type A : Europe Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
8.4 Influenza Virus Type B
8.4.1 Overview
8.4.2 Influenza Virus Type B : Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
9. Europe Influenza Vaccines Market Analysis and Forecasts To 2028 - By Technology
9.1 Overview
9.2 Europe Influenza Vaccines Market, By Technology 2022 & 2028 (%)
9.2.1 Europe: Influenza Vaccines Market, by Technology, 2019-2028 (US$ Million)
9.3 Egg-based
9.3.1 Overview
9.3.2 Egg-based : Europe Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
9.4 Cell-based
9.4.1 Overview
9.4.2 Cell-Based : Europe Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
10. Europe Influenza Vaccines Market Analysis and Forecasts To 2028 - By Route of Administration
10.1 Overview
10.2 Europe Influenza Vaccines Market, By Route of Administration 2022 & 2028 (%)
10.2.1 Europe: Influenza Vaccines Market, by Route of Administration, 2019-2028 (US$ Million)
10.2.2 Europe: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
10.3 Injection
10.3.1 Overview
10.3.2 Injection : Europe Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
10.4 Nasal Spray
10.4.1 Overview
10.4.2 Nasal Spray: Europe Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
11. Europe Influenza Vaccines Market Analysis and Forecasts To 2028 - By Target Group
11.1 Overview
11.2 Europe Influenza Vaccines Market, By Target Group 2022 & 2028 (%)
11.2.1 Europe: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
11.3 Infants
11.3.1 Overview
11.3.2 Infants : Europe Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
11.4 Children
11.4.1 Overview
11.4.2 Children: Europe Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
11.5 Adults
11.5.1 Overview
11.5.2 Adults : Europe Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
11.6 Elderly People
11.6.1 Overview
11.6.2 Elderly People: Europe Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
12. Europe Influenza Vaccines Market Analysis and Forecasts To 2028 - Country Analysis
12.1 Europe: Influenza Vaccines Market
12.1.1 Overview
12.1.2 Europe: Influenza Vaccines Market, by Country, 2022 & 2028 (%)
12.1.2.1 Germany: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
12.1.2.1.1 Overview
12.1.2.1.2 Germany: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
12.1.2.1.3 Germany: Influenza Vaccines Market, by Vaccine Type, 2019-2028 (US$ Million)
12.1.2.1.4 Germany: Influenza Vaccines Market, by Virus Type, 2019-2028 (US$ Million)
12.1.2.1.5 Germany: Influenza Vaccines Market, by Technology, 2019-2028 (US$ Million)
12.1.2.1.6 Germany: Influenza Vaccines Market, by Route of Administration, 2019-2028 (US$ Million)
12.1.2.1.7 Germany: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
12.1.2.2 UK: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
12.1.2.2.1 Overview
12.1.2.2.2 UK: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
12.1.2.2.3 UK: Influenza Vaccines Market, by Vaccine Type, 2019-2028 (US$ Million)
12.1.2.2.4 UK: Influenza Vaccines Market, by Virus Type, 2019-2028 (US$ Million)
12.1.2.2.5 UK: Influenza Vaccines Market, by Technology, 2019-2028 (US$ Million)
12.1.2.2.6 UK: Influenza Vaccines Market, by Route of Administration, 2019-2028 (US$ Million)
12.1.2.2.7 UK: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
12.1.2.3 France: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
12.1.2.3.1 Overview
12.1.2.3.2 France: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
12.1.2.3.3 France: Influenza Vaccines Market, by Vaccine Type, 2019-2028 (US$ Million)
12.1.2.3.4 France: Influenza Vaccines Market, by Virus Type, 2019-2028 (US$ Million)
12.1.2.3.5 France: Influenza Vaccines Market, by Technology, 2019-2028 (US$ Million)
12.1.2.3.6 France: Influenza Vaccines Market, by Route of Administration, 2019-2028 (US$ Million)
12.1.2.3.7 France: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
12.1.2.4 Italy: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
12.1.2.4.1 Overview
12.1.2.4.2 Italy: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
12.1.2.4.3 Italy: Influenza Vaccines Market, by Vaccine Type, 2019-2028 (US$ Million)
12.1.2.4.4 Italy: Influenza Vaccines Market, by Virus Type, 2019-2028 (US$ Million)
12.1.2.4.5 Italy: Influenza Vaccines Market, by Technology, 2019-2028 (US$ Million)
12.1.2.4.6 Italy: Influenza Vaccines Market, by Route of Administration, 2019-2028 (US$ Million)
12.1.2.4.7 Italy: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
12.1.2.5 Spain: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
12.1.2.5.1 Overview
12.1.2.5.2 Spain: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
12.1.2.5.3 Spain: Influenza Vaccines Market, by Vaccine Type, 2019-2028 (US$ Million)
12.1.2.5.4 Spain: Influenza Vaccines Market, by Virus Type, 2019-2028 (US$ Million)
12.1.2.5.5 Spain: Influenza Vaccines Market, by Technology, 2019-2028 (US$ Million)
12.1.2.5.6 Spain: Influenza Vaccines Market, by Route of Administration, 2019-2028 (US$ Million)
12.1.2.5.7 Spain: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
12.1.2.6 Rest of Europe: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
12.1.2.6.1 Overview
12.1.2.6.2 Rest of Europe: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
12.1.2.6.3 Rest of Europe: Influenza Vaccines Market, by Vaccine Type, 2019-2028 (US$ Million)
12.1.2.6.4 Rest of Europe: Influenza Vaccines Market, by Virus Type, 2019-2028 (US$ Million)
12.1.2.6.5 Rest of Europe: Influenza Vaccines Market, by Technology, 2019-2028 (US$ Million)
12.1.2.6.6 Rest of Europe: Influenza Vaccines Market, by Route of Administration, 2019-2028 (US$ Million)
12.1.2.6.7 Rest of Europe: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
13. Europe Influenza Vaccine Market -Industry Landscape
13.1 Overview
13.2 Growth Strategies in the Influenza Vaccine Market, 2021-2028
13.3 Inorganic Growth Strategies
13.3.1 Overview
13.4 Organic Growth Strategies
13.4.1 Overview
14. Company Profiles
14.1 Moderna, Inc.
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 SEQIRUS
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Sanofi
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 GlaxoSmithKline plc.
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Emergent BioSolutions Inc.
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Mitsubishi Chemical Group Corporation
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Serum Institute of India Pvt. Ltd
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 MYLAN N.V.
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 AstraZeneca
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
15. Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms
LIST OF TABLES
Table 1. Below are a few instances of companies and their pipeline products:
Table 2. Europe Influenza Vaccines Market- Revenue and Forecast to 2028 (US$ Million)
Table 3. Europe Influenza Vaccines Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
Table 4. Europe: Influenza Vaccines Market, by Virus Type - Revenue and Forecast to 2028 (US$ Million)
Table 5. Europe Influenza Vaccines Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 6. Europe Influenza Vaccines Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
Table 7. Europe Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
Table 8. Germany Influenza Vaccines Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
Table 9. Germany: Influenza Vaccines Market, by Virus Type - Revenue and Forecast to 2028 (US$ Million)
Table 10. Germany Influenza Vaccines Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 11. Germany Influenza Vaccines Market, by Route of Administration- Revenue and Forecast to 2028 (US$ Million)
Table 12. Germany Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
Table 13. UK Influenza Vaccines Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
Table 14. UK: Influenza Vaccines Market, by Virus Type - Revenue and Forecast to 2028 (US$ Million)
Table 15. UK Influenza Vaccines Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 16. UK Influenza Vaccines Market, by Route of Administration- Revenue and Forecast to 2028 (US$ Million)
Table 17. UK Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
Table 18. France Influenza Vaccines Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
Table 19. France: Influenza Vaccines Market, by Virus Type - Revenue and Forecast to 2028 (US$ Million)
Table 20. France Influenza Vaccines Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 21. France Influenza Vaccines Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
Table 22. France Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
Table 23. Italy Influenza Vaccines Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
Table 24. Italy: Influenza Vaccines Market, by Virus Type - Revenue and Forecast to 2028 (US$ Million)
Table 25. Italy Influenza Vaccines Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 26. Italy Influenza Vaccines Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
Table 27. Italy Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
Table 28. Spain Influenza Vaccines Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
Table 29. Spain: Influenza Vaccines Market, by Virus Type - Revenue and Forecast to 2028 (US$ Million)
Table 30. Spain Influenza Vaccines Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 31. Spain Influenza Vaccines Market, by Route of Administration- Revenue and Forecast to 2028 (US$ Million)
Table 32. Spain Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
Table 33. Rest of Europe Influenza Vaccines Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
Table 34. Rest of Europe: Influenza Vaccines Market, by Virus Type - Revenue and Forecast to 2028 (US$ Million)
Table 35. Rest of Europe Influenza Vaccines Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 36. Rest of Europe Influenza Vaccines Market, by Route of Administration- Revenue and Forecast to 2028 (US$ Million)
Table 37. Rest of Europe Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
Table 38. Recent Inorganic Growth Strategies in the Influenza Vaccine Market
Table 39. Recent Organic Growth Strategies in the Influenza Vaccine Market
Table 40. Glossary of Terms, Influenza Vaccines Market
LIST OF FIGURES
Figure 1. Europe Influenza Vaccines Market Segmentation
Figure 2. Europe Influenza Vaccines Market Segmentation, by Country
Figure 3. Europe Influenza Vaccines Market Overview
Figure 4. Quadrivalent Vaccines Segment Held Largest Share of Product Segment in Europe Influenza Vaccines Market
Figure 5. UK Is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Europe: PEST Analysis
Figure 7. Experts Opinion
Figure 8. Europe Influenza Vaccines Market - Revenue Forecasts and Analysis - 2020- 2028
Figure 9. Europe Influenza Vaccines Market, by Vaccine Type 2022 & 2028 (%)
Figure 10. Quadrivalent Vaccines: Europe Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 11. Trivalent Vaccines: Europe Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 12. Europe Influenza Vaccines Market, by Virus Type 2022 & 2028 (%)
Figure 13. Influenza Virus Type A : Europe Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 14. Influenza Virus Type B: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 15. Europe Influenza Vaccines Market, by Technology 2022 & 2028 (%)
Figure 16. Egg-based: Europe Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 17. Cell-Based: Europe Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 18. Europe Influenza Vaccines Market, by Route of Administration 2022 & 2028 (%)
Figure 19. Injection: Europe Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 20. Nasal Spray: Europe Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 21. Europe Influenza Vaccines Market, by Target Group 2022 & 2028 (%)
Figure 22. Infants : Europe Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 23. Children: Europe Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 24. Adults: Europe Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 25. Elderly People: Europe Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 26. Europe: Influenza Vaccines Market, by Key Country - Revenue (2022) (US$ Million)
Figure 27. Europe: Influenza Vaccines Market, by Country, 2022 & 2028 (%)
Figure 28. Germany: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
Figure 29. UK: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
Figure 30. France: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
Figure 31. Italy: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
Figure 32. Spain: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
Figure 33. Rest of Europe: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
Figure 34. Growth Strategies in the Influenza Vaccine Market, 2021-2028
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security